MedPath

A cohort study of the performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0008182
Lead Sponsor
Wonkwang University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Patients who successfully received a drug-eluting stent after diagnosis of acute coronary syndrome
2. Patients who voluntarily participated in this study and gave written consent

Exclusion Criteria

1. Age less than 19 years
2. Contraindications to prasugrel or ticagrelor: history of intracranial hemorrhage, active bleeding, etc.
3. Subjects whose life expectancy is less than 1 year
4. Subjects who are judged unsuitable by investigators

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of stent thrombosis
Secondary Outcome Measures
NameTimeMethod
Target vessek failure
© Copyright 2025. All Rights Reserved by MedPath